Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT02354131 |
Title | Niraparib Versus Niraparib-bevacizumab Combination in Women With Platinum-sensitive Epithelial Ovarian Cancer (AVANOVA) |
Recruitment | Active, not recruiting |
Gender | male |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | Nordic Society for Gynaecologic Oncology |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA |